The Effect Of Awareness-Based Self-Compassage Educatıon Gıven To Women Experıenced Sexual Dysfunctıon In The Postpartum Perıod On The Qualıty Of Sexual Lıfe And Partnershıp

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Sexual function in the postpartum period, the gateway to newness and change, can be affected by problems such as caring for a new baby, breastfeeding, fatigue, anxiety about pain during sexual intercourse, postpartum depression, pelvic floor dysfunction, urinary symptoms and body image. Changes in sexual function are common in the postpartum period. Pregnancy and childbirth is a period in a woman's life that causes hormonal and physical changes and has an impact on the parents' quality of life. Postpartum sexual function is an important issue for couples, as the first sexual intercourse after childbirth is an important step for couples to establish intimate relationships. Many factors affect postpartum sexual dysfunction, including number of births, breastfeeding, mode of delivery, episiotomy, physical and psychological dysfunction, including fatigue and postpartum depression. Without adequate information and counseling on sexual life by health professionals in the postpartum period, most women may remain silent about their sexual concerns and anxieties, preferring instead to share their problems with friends. More holistic and multidisciplinary approaches are needed to treat female sexual dysfunctions. The use of mindfulness-based therapies has recently become widespread in the treatment of women diagnosed with sexual dysfunction.Thanks to mindfulness practices, it has been observed that women perceive stimuli better and are able to notice clues that they did not notice before. The Compassion Focused Therapy program is one of these practices. It is known to integrate well with existing approaches to therapy and offers some useful ways of reducing sexual problems to provide a coherent rationale for treatment strategies.

Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:

• Erbal communicator and no literacy disability,

• Living with his wife,

• Beginning postpartum sexual intercourse, menstrual cycle has not started

• Between 2-6 months postpartum,

• Having a healthy baby

• Menstrual cycle has not started

• Women diagnosed with sexual dysfunction (total score ≥19) according to the Arizona

• Sexual Experiences Scale will be included in the study.

Locations
Other Locations
Turkey
Gaziantep Provincial Directorate of Health
RECRUITING
Gaziantep
Contact Information
Primary
Fadime Biçer Şahin, MSc
fadimebicer42@gmail.com
05522980842
Time Frame
Start Date: 2024-02-05
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 108
Treatments
Experimental: Sexual Dysfunction in the Postpartum Period
In the research, Awareness-Based Self-Compassion Training sessions will be held with the women in the experimental group twice a week for 3 weeks, six times in total.Women in the postpartum period included in the control group will be interviewed twice in total. In the first interview, the Personal Information Form, Sexual Life Quality Scale-Female and Male Compatibility Scale will be applied and pre-test data will be obtained. Eight weeks after the pre-test data is obtained, post-test data will be obtained by applying the Arizona Sexual Experiences Scale-Female, Sexual Quality of Life Scale-Female and Dutch Compatibility Scale.
No_intervention: control
Women in the postpartum period included in the control group will be interviewed twice in total. In the first interview, the Personal Information Form, Sexual Life Quality Scale-Female and Male Compatibility Scale will be applied and pre-test data will be obtained. Eight weeks after the pre-test data is obtained, post-test data will be obtained by applying the Arizona Sexual Experiences Scale-Female, Sexual Quality of Life Scale-Female and Dutch Compatibility Scale.
Related Therapeutic Areas
Sponsors
Leads: Inonu University

This content was sourced from clinicaltrials.gov